EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Screening for latent tuberculosis infection in patients with chronic kidney disease: a review of evidence and current practice in the UK

Joseph Sturman iD, Jyoti Baharani, Jed Ashman, Lorraine Harper iD, Adam F Cunningham, Martin Dedicoat, Matthew K O'Shea

Clinical Kidney Journal · 02.07.2025 · 18 (7)

DOI: 10.1093/ckj/sfaf197 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Kidney Journal, online erschienen am 19.06.2025. Verfasst von Joseph Sturman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Immunotherapy, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingha…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kidney Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB) and chronic kidney disease (CKD) represent an extant local and global syndemic, with TB incidence rates in the UK end-stage renal failure population far surpassing those of the general population in endemic countries. Patients with CKD generally have latent TB reactivation, rather than de novo infection, which presents with atypical, non-pulmonary presentations leading to late diagnosis, poorer outcomes and a high risk of widespread transmission through haemodialysis units. There is therefore a need to consider latent TB infection screening in the CKD population. However, there is widespread variation in local screening practices in the UK due to the challenge of diagnosing latent TB in CKD, and the absence of robust evidence-based guidelines. There is also concern that although a screening programme may have significant public health benefit, it may cause harm to the individual patient through adverse effects of treatment. In this review, we present the current evidence for latent TB infection screening in CKD, including the evidence of benefit and harm to the individual and the public. We also review current practices in the UK and present survey data from renal units in England demonstrating the diversity of policies currently in place. We advocate screening for latent TB in all CKD patients commencing dialysis and we highlight the pressing research questions that need to be urgently answered to help move towards a cohesive national policy to help drive evidence-based consistent care.

Schlagwörter

Stichwörter der Autor:innen

chronic kidney diseasescreeningtuberculosis

Autor:innen und Institutionen

  • Department of Immunology and Immunotherapy, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK.
  • Department of Renal Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Department of Applied Health Sciences, School of Health Sciences, University of Birmingham, Birmingham, UK.
  • Department of Infectious Diseases, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

ORCID-Profile: Joseph Sturman, Lorraine Harper

Förderung

  • Kidney Research UK

Zitieren

APA

Sturman, J., Baharani, J., Ashman, J., Harper, L., Cunningham, A. F., Dedicoat, M., & O'Shea, M. K. (2025). Screening for latent tuberculosis infection in patients with chronic kidney disease: a review of evidence and current practice in the UK. Clinical Kidney Journal, 18(7). https://doi.org/10.1093/ckj/sfaf197

Vancouver

Sturman J, Baharani J, Ashman J, Harper L, Cunningham AF, Dedicoat M, et al. Screening for latent tuberculosis infection in patients with chronic kidney disease: a review of evidence and current practice in the UK. Clinical Kidney Journal. 2025;18(7). doi:10.1093/ckj/sfaf197

BibTeX
@article{Sturman2025,
  author = {Sturman, Joseph and Baharani, Jyoti and Ashman, Jed and Harper, Lorraine and Cunningham, Adam F and Dedicoat, Martin and O'Shea, Matthew K},
  title = {Screening for latent tuberculosis infection in patients with chronic kidney disease: a review of evidence and current practice in the UK},
  journal = {Clinical Kidney Journal},
  year = {2025},
  volume = {18},
  number = {7},
  doi = {10.1093/ckj/sfaf197}
}
Kostenlos starten →